Armata Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $2,510 | $789 | $1,085 | $1,159 |
Gross Profit | 1,919 | 332 | 667 | 789 |
EBITDA | 81,366 | -109,330 | -119,046 | -21,959 |
EBIT | 80,775 | -109,787 | -119,464 | -22,329 |
Net Income | 74,141 | -115,346 | -124,298 | -26,675 |
Net Change In Cash | 2,510 | 789 | 1,085 | 1,159 |
Free Cash Flow | -8,683 | -5,845 | -6,726 | -4,540 |
Cash | 23,952 | 4,754 | 8,688 | 14,756 |
Basic Shares | 62,041 | 36,530 | 36,344 | 36,226 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,904 | $5,174 | $4,529 | $5,508 |
Gross Profit | 3,373 | -29,252 | 3,557 | -29,509 |
EBITDA | -155,678 | -6,849 | -65,447 | -35,996 |
EBIT | -157,209 | -8,174 | -66,419 | -36,888 |
Net Income | -173,799 | -18,916 | -69,045 | -36,917 |
Net Change In Cash | 4,904 | 5,174 | 4,529 | 5,508 |
Cost of Revenue | 9,324 | |||
Free Cash Flow | -26,305 | -39,430 | -55,567 | -34,692 |
Cash | 8,688 | 9,291 | 13,523 | 14,852 |
Basic Shares | 36,239 | 36,160 | 36,075 | 34,294 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.27 |
2026-03-31 | -$3.16 |
2025-12-31 | -$0.51 |
2025-09-30 | -$0.33 |